Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation
- 15 October 2008
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (20), 10143-10152
- https://doi.org/10.1128/jvi.00688-08
Abstract
Recovery of human cytomegalovirus (HCMV)-specific T immunity is critical for protection against HCMV disease in the early phase after allogeneic stem cell transplantation (SCT). Using an enzyme-linked immunospot assay with overlapping 15-mer peptides spanning pp65 and immediate-early 1 HCMV proteins, we investigated which HCMV-specific CD8(+) gamma interferon-positive (IFN-gamma(+)) T-cell responses against pp65 and IE-1 were associated with control of HCMV replication in 48 recipients of unmanipulated HLA-matched allografts at 3 months (M3) and 6 months (M6) after SCT and in 23 donors. At M3 after SCT, the magnitude of the pp65-specific IFN-gamma-producing CD8(+) T-cell response was greater in recipients than in donors, regardless of HCMV status. In contrast, expansion of IE-1-specific CD8(+) T cells at M3 was associated with protection against HCMV, and no patient with this expansion had HCMV replication at M3. At M6, the number of HCMV-specific CD8(+) T cells against both pp65 and IE-1 had expanded in all recipients, regardless of their previous levels of HCMV replication. The recipients' HCMV-specific CD8(+) T cells already detectable in related donors were predominantly targeting pp65. In contrast, in 40% of the cases, the HCMV-specific CD8(+) T cells in recipients involved new CD8(+) T-cell specificities undetectable in their related donors and preferentially targeting IE-1. Taken together, these results showed that the delay in reconstituting IE-1-specific CD8(+) T cells is correlated with the lack of protection against HCMV in the first 3 months after SCT. They also show that IE-1 is a major antigenic determinant of the early restoration of protective immunity to HCMV after SCT.Keywords
This publication has 43 references indexed in Scilit:
- Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole bloodJournal of Clinical Virology, 2007
- Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant RecipientsThe Journal of Infectious Diseases, 2006
- Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infectionThe Journal of Experimental Medicine, 2006
- Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complicationsBlood, 2005
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsThe Journal of Experimental Medicine, 2005
- Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus diseaseThe Journal of Experimental Medicine, 2005
- Clinical aspects of cmv infection after stem cell transplantationHuman Immunology, 2004
- Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantationBlood, 2003
- Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus CarriersJournal of Virology, 2003
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982